|
Hematology and Hemostasis |
1446 |
Transcriptome-wide Association Study of Blood Cell Traits in TOPMed |
Alex Reiner |
|
Hematology and Hemostasis |
6535 |
Transcriptomics of clonal hematopoiesis of indeterminate potential |
Seyedeh Maryam Zekavat |
|
Hematology and Hemostasis |
257 |
WGS of CVD risk factors and biomarkers in FHS |
Caroline Fox |
|
Hematology and Hemostasis |
969 |
Whole genome sequence analysis of coagulation factor VIII (FVIII) and von Willebrand factor (vWF) across TOPMed studies |
Nicholas Smith |
|
Hematology and Hemostasis |
258 |
Whole genome sequence analysis of coronary heart disease and its risk factors in the Jackson Heart Study |
James Wilson |
|
Hematology and Hemostasis |
970 |
Whole genome sequence analysis of D-dimer, tissue plasminogen activator (tPA), and plasminogen activator inhibitor (PAI-1) across TOPMed studies |
Nicholas Smith |
|
Hematology and Hemostasis |
968 |
Whole genome sequence analysis of fibrinogen and coagulation factor VII (FVII) across TOPMed studies |
Nicholas Smith |
|
Hematology and Hemostasis |
259 |
Whole genome sequence analysis of hematologic traits in the Jackson Heart Study |
James Wilson |
|
Hematology and Hemostasis |
5688 |
Whole Genome Sequence Analysis of Risk Factors for and Sequelae from Hypertension in the Genetic Epidemiology of Arteriopathy (GENOA) cohort in the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program |
Patricia Peyser |
|
Hematology and Hemostasis |
2008 |
Whole Genome Sequence Analysis of Risk Factors for and Sequelae from Hypertension in the Genetic Epidemiology of Arteriopathy (GENOA) cohort in the NHLBI Trans-Omics for Precision Medicine (TOPMed) Program |
Patricia Peyser |
